News | April 07, 2022
Indian pharma growth likely to moderate in FY23: ICRA
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
BioFluidica LiquidScan harnesses the power of microfluidics
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
Subscribe To Our Newsletter & Stay Updated
